Joint Policy 2012-02 and FAQs on Pharmacist Administration of Vaccines
Electronic Transfers of Walgreens Prescriptions
Advisory on Stock Supply of Epi-Pens for Schools
2012-01 Permitted Prescription Changes and Additions after Consultation with Prescriber Schedule II - VI
Model Agreement for CDTM Hospital Pharmacy Practice
Emergency Contraception Pharmacy Board Advisory
EPT Pharmacy Board Advisory
PMP & Mandatory Educational Requirements for Prescribers (CDTM Pharmacists)
Prescription Monitoring Program (PMP) Information
Clarification Regarding Authorized Vaccinators for the 2010-2011 Influenza Season
Model Agreement for Collaborative Drug Therapy Management (CDTM) for Community Pharmacy Practice Settings
New Section 16.00 of 247 CMR: Collaborative Drug Therapy Management (CDTM)
-
Duty to Report Certain Improper Drug Dispensing to the Board
Includes the Pharmacy Report of Improper Drug Dispensing Resulting in Serious Injury or Death Form. Pharmacies Advised to Assess Antiviral Medication Inventory Needs
-
Public Hearing Notice Re. Drug Dispensing Error Reporting
-
Purchase and Sale of Needles & Syringes
This Relates to the Purchase and Possession of Needles and Syringes in The Commonwealth. -
Proper Use and Disposal of Needles and Syringes
-
FAQ's on PMP Amendments
-
DEA Notice of Public Rulemaking
Regarding Electronic Prescriptions for Controlled Substances. -
Heparin & Heparin-containing Medical Products
Update to Healthcare Facilities and Healthcare Professionals. Tamper Resistant Prescription Requirements
Tamper Resistant Prescription Updates
-
2007-01: Joint Policy regarding Issuance of Multiple Prescriptions for Schedule II Controlled Substances
-
DEA Notice on Diversion Trends via the Internet
-
Tamper-Resistant Rx Pad Law Delay
Bush Approves Six-Month Delay in Implementing Tamper-Resistant Rx Pad Law -
Tamper Resistant Prescription Pad Guidance
-
Risks of Obtaining Prescription Drugs Without Proper Medical Care
-
Public Hearing on Proposed Amendments to CMR Title 247